Related Experiment Video
Updated: Jun 4, 2026

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
Epidermal growth factor receptor as a biomarker for cervical cancer
T Soonthornthum1, H Arias-Pulido, N Joste
1Department of Internal Medicine, University of New Mexico Cancer Research and Treatment Center, Albuquerque, NM 87131, USA.
Abstract:
This review focuses on the different modes of expression of the epidermal growth factor receptor (EGFR). All methods used to assess EGFR expression are critically analyzed and insights into the use of inhibitors of EGFR for treatment of cervical cancer are discussed. Currently, expression of EGFR as a biomarker for prognosis or for treatment of cervical cancer is not defined for clinical use.
